Investigating new therapies for Autosomal Polycystic Kidney Disease (ADPKD)
Clinical and Translational Core
This study is looking at how Autosomal Polycystic Kidney Disease (ADPKD) progresses and aims to find new treatments by working with 200 patients to gather important health information and biological samples, which will help researchers discover helpful markers and genetic details about the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10886674 on NIH RePORTER |
What this research studies
This research focuses on understanding the progression of Autosomal Polycystic Kidney Disease (ADPKD) and aims to identify new therapies. It involves a comprehensive approach that includes studying 200 ADPKD patients, collecting detailed clinical data, and creating a biorepository of human tissue and cell cultures. The project will also develop an electronic registry to facilitate patient recruitment for clinical trials. By linking patient data with biological samples, the research seeks to uncover important biomarkers and genetic information related to ADPKD.
Who could benefit from this research
Good fit: Ideal candidates for participation are adults aged 21 and older diagnosed with Autosomal Polycystic Kidney Disease.
Not a fit: Patients with conditions other than Autosomal Polycystic Kidney Disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies and better management of Autosomal Polycystic Kidney Disease for patients.
How similar studies have performed: Previous research has shown promise in similar approaches to understanding and treating ADPKD, indicating potential for success in this investigation.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Seliger, Stephen L. — University of Maryland Baltimore
- Study coordinator: Seliger, Stephen L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.